Anti-human IL23A Recombinant Antibody (TAB-620LC)
This recombinant monoclonal antibody is a humanized monoclonal antibody that specifically recognizes human IL-23A and has potent affinity against IL-23A. It can also be potentially used in the research of Crohn's disease, psoriasis, psoriatic arthritis, and asthma.
Anti-human IL23A Recombinant Antibody (TAB-620LC)
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
This recombinant monoclonal antibody is a humanized monoclonal antibody that specifically recognizes human IL-23A and has potent affinity against IL23A. It also can be potentially used in the research of Crohn's disease, psoriasis, psoriatic arthritis and asthma. It is designed to support reliable, reproducible results in modern laboratories. It helps streamline your workflow, reduce troubleshooting, and deliver consistent performance across batches. Prominent attributes include productname and abbr.
Manufactured under rigorous quality controls, each lot is checked for key specifications to ensure lot‑to‑lot consistency. The format is optimized for ease of use and integration into existing protocols, with documentation available upon request.
Key Features / Benefits
- productname: Anti-human IL23A Recombinant Antibody (TAB-620LC)
- abbr: Anti-human IL23A Antibody (TAB-620LC)
- Target: IL23A
- Host Animal: Human
- Specificity: Human
- Antibody Isotype: IgG
Relevant Applications
- ELISA
